Header cover image

Hong Kong (HSI) Healthcare Sector Analysis

UpdatedMar 28, 2024
DataAggregated Company Financials
Companies195
  • 7D-2.8%
  • 3M-17.3%
  • 1Y-35.5%
  • YTD-16.2%

Over the last 7 days, the Healthcare industry has dropped 1.9%, driven by pullbacks in Akeso and Genscript Biotech of 8.0% and 10%, respectively. The industry has fallen 36% in the last year. Earnings are forecast to grow by 24% annually.

Sector Valuation and Performance

Has the Hong Kong Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 28 Mar 2024HK$1.3tHK$1.4tHK$28.6b11.8x46x0.9x
Sat, 24 Feb 2024HK$1.3tHK$1.4tHK$27.1b11.6x49.7x0.9x
Mon, 22 Jan 2024HK$1.4tHK$1.4tHK$26.0b11.4x52.6x1x
Wed, 20 Dec 2023HK$1.5tHK$1.4tHK$26.4b12.9x57.6x1.1x
Fri, 17 Nov 2023HK$1.7tHK$1.4tHK$25.2b12.8x66.6x1.2x
Sun, 15 Oct 2023HK$1.6tHK$1.4tHK$24.6b12.3x65.8x1.2x
Tue, 12 Sep 2023HK$1.6tHK$1.4tHK$25.2b12.7x63.2x1.1x
Thu, 10 Aug 2023HK$1.6tHK$1.3tHK$14.1b13.9x114.9x1.2x
Sat, 08 Jul 2023HK$1.7tHK$1.4tHK$2.5b13x669.2x1.2x
Mon, 05 Jun 2023HK$1.7tHK$1.3tHK$3.2b14x542.3x1.3x
Wed, 03 May 2023HK$1.9tHK$1.4tHK$4.4b16.9x436.2x1.4x
Fri, 31 Mar 2023HK$1.8tHK$1.4tHK$12.1b16.7x152.2x1.4x
Sun, 26 Feb 2023HK$1.9tHK$1.3tHK$2.0b16.1x948.2x1.4x
Tue, 24 Jan 2023HK$2.1tHK$1.4tHK$2.2b15.8x936.5x1.5x
Thu, 22 Dec 2022HK$1.8tHK$1.3tHK$2.1b14.1x840.4x1.4x
Sat, 19 Nov 2022HK$1.8tHK$1.3tHK$1.0b12.9x1734.1x1.4x
Mon, 17 Oct 2022HK$1.5tHK$1.3tHK$2.6b12.7x595.5x1.2x
Wed, 14 Sep 2022HK$1.7tHK$1.3tHK$3.2b14.3x535.4x1.3x
Fri, 12 Aug 2022HK$1.8tHK$1.3t-HK$1,267,429,553.0013.6x-1431.1x1.4x
Sun, 10 Jul 2022HK$2.0tHK$1.3t-HK$1,022,224,302.0014.8x-1946.5x1.5x
Tue, 07 Jun 2022HK$1.7tHK$1.3t-HK$2,377,962,011.0013.5x-702.8x1.3x
Thu, 05 May 2022HK$1.6tHK$1.3t-HK$3,017,666,342.0013.4x-529.4x1.2x
Sat, 02 Apr 2022HK$1.8tHK$1.4tHK$247.0m14.4x7202.2x1.3x
Mon, 28 Feb 2022HK$2.0tHK$1.3tHK$10.1b14.1x197x1.5x
Wed, 26 Jan 2022HK$2.1tHK$1.3tHK$7.9b15x267.9x1.6x
Fri, 24 Dec 2021HK$2.3tHK$1.3tHK$8.0b14.7x283.5x1.7x
Sun, 21 Nov 2021HK$2.6tHK$1.3tHK$8.0b15.7x329.8x2x
Tue, 19 Oct 2021HK$2.7tHK$1.3tHK$7.9b15.6x341.2x2.1x
Thu, 16 Sep 2021HK$2.7tHK$1.3tHK$7.8b15.8x345.7x2.1x
Sat, 14 Aug 2021HK$3.1tHK$1.3tHK$7.5b17.4x414.6x2.4x
Wed, 09 Jun 2021HK$3.8tHK$1.2t-HK$1,960,161,127.5421.1x-1923.3x3.1x
Price to Earnings Ratio

81074.8x


Total Market Cap: HK$3.4tTotal Earnings: HK$42.2mTotal Revenue: HK$1.2tTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Sector Price to Earnings3Y Average 2290.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 46.0x which is lower than its 3-year average PE of 2kx.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 0.92x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 779% per year over the last three years.
  • Revenues for these companies have grown 5.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare sector?

HK Market-0.59%
Healthcare-2.82%
Pharma-0.79%
Healthcare Services-1.08%
Healthtech-1.60%
Life Sciences-3.48%
Medical Equipment-4.94%
Biotech-5.48%
Industry PE
  • Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 154x.
    • Analysts are expecting annual earnings growth of 41.0%, which is higher than its past year's earnings decline of 10.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 41% over the next 5 years.
  • This is better than its past earnings decline of 11% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3692 Hansoh Pharmaceutical GroupHK$15.484.2%
+HK$3.7b
15.0%PE25.8x
6078 Hygeia Healthcare HoldingsHK$31.9013.9%
+HK$2.5b
-41.9%PE27.2x
2005 SSY GroupHK$5.1610.3%
+HK$1.4b
11.7%PE11.6x
1530 3SBioHK$5.9810.1%
+HK$1.3b
-25.3%PE6.9x
2179 Jiangsu Recbio TechnologyHK$9.8022.5%
+HK$864.6m
-57.8%PS143.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2005

HK$5.16

SSY Group

7D

10.3%

1Y

11.7%

1066

HK$4.88

Shandong Weigao Group Medical Polymer

7D

-7.6%

1Y

-60.3%

867

HK$8.22

China Medical System Holdings

7D

-34.8%

1Y

-34.4%

6078

HK$31.90

Hygeia Healthcare Holdings

7D

13.9%

1Y

-41.9%

1345

HK$1.88

Shanghai Pioneer Holding

7D

32.4%

1Y

-24.5%

1541

HK$16.14

ImmuneOnco Biopharmaceuticals (Shanghai)

7D

9.1%

1Y

n/a

1099

HK$20.05

Sinopharm Group

7D

-4.5%

1Y

-13.4%

6606

HK$14.14

New Horizon Health

7D

-23.1%

1Y

-47.1%

1548

HK$14.50

Genscript Biotech

7D

-6.6%

1Y

-19.4%

1093

HK$6.15

CSPC Pharmaceutical Group

7D

-5.2%

1Y

-18.1%

1530

HK$5.98

3SBio

7D

10.1%

1Y

-25.3%

2509

HK$23.55

Qyuns Therapeutics

7D

16.9%

1Y

n/a

9877

HK$5.41

Jenscare Scientific

7D

-45.7%

1Y

-85.6%